Many people with constipation are confused about the cause of their condition and its appropriate treatment with laxatives. Results of a new large-scale global survey, announced today, show that many people wrongly fear that laxatives are addictive and that their use for long periods of time actually causes constipation.1,2
Poor adherence to medication is a recognized medical problem, costing an estimated $100 billion a year in the United States.(i) New data show that while there is a steady decline in adherence to medications for ulcerative colitis (UC), drug formulation and the number of pills taken each day do not affect long-term adherence. The data were presented today at the annual scientific meeting of the American College of Gastroenterology by University of Chicago researcher Sunanda Kane, M.D.
Abbott announced results from a study showing HUMIRA? (adalimumab) induced significantly higher rates of clinical remission compared to placebo in patients with moderately to severely active Crohn’s disease who lost response to, or were intolerant to, infliximab therapy. The data is being presented simultaneously at the American College of Gastroenterology (ACG) annual meeting in Las Vegas and the United European Gastroenterology Week (UEGW) in Berlin.
Although moderate alcohol intake is associated with lower risk for myocardial infarction (MI), guidelines generally suggest that adults seek other lifestyle measures to reduce cardiovascular risk. Physical activity, smoking, and diet, moderate alcohol intake is associated with lower risk for MI.
Exercise alone won’t help you lose weight if you continue eating an unhealthy diet. That’s the conclusion of an Australian review of 43 weight-loss studies dating back to 1985. “Exercise by itself is not going to be an effective weight-loss strategy for an individual, you really need to combine exercise with better nutrition,” review lead author Dr. Kelly Shaw, a public health doctor with the department of health and human services in Tasmania, said in a prepared statement.
Substantial nutrient loss in food occurs in hospital foodservice operations, according to research recently published in the Journal of Foodservice. The study quantifies how much Vitamin C, as a marker of nutrient quality, is retained at various stages of processing at two New Jersey hospitals.
US scientists have come up with a new way to determine whether someone is suffering from an eating disorder – examining their hair. A study released by researchers from Utah’s Brigham Young University found that examining carbon and nitrogen in the proteins of hair could reveal information about a person’s day-to-day nutrition.
Diet plays a key role in controlling your blood sugar. A healthy-eating plan tailored to your needs will do that and more. Majority of people affected with diabetes are overweight or obese. In fact, your risk of getting diabetes increases the more weight you put on.
Novartis announced the start of GALIANT, a significant clinical trial set to involve more than 7,500 people in the United States comparing the investigational oral type 2 diabetes medication Galvus? (vildagliptin) with commonly prescribed anti-diabetic oral medicines called thiazolidinediones (TZDs).
Manhattan Pharmaceuticals, Inc. (Amex: MHA) today announced expansion of its oral Oleoyl-estrone (OE) clinical obesity program to include the morbidly obese. A new US Phase 2a clinical trial evaluating oral OE in morbidly obese male subjects will be initiated in October 2006. The morbidly obese population in the US is estimated to be 14 million people. OE is the Company’s orally administered product candidate in development for the treatment of obesity.